Division of Endocrinology, Diabetes & Metabolism

Department of Medicine

Alicia Jacobs, M.D., associate professor of family medicine (left), and Jason Sanders, M.D., M.B.A., president and CEO of the UVM Medical Group

(JULY 9, 2024) Alicia Jacobs, M.D., associate professor of family medicine, and Jason Sanders, M.D., M.B.A., assistant professor of medicine and senior associate dean for clinical affairs at the Larner College of Medicine and president and CEO of the UVM Medical Group, commented to Healthcare Finance News for a story about a new partnership between the University of Vermont Health Network and Abridge to use AI for clinical documentation.

The AI clinical platform has been shown to increase clinicians’ professional fulfillment by 53 percent; decrease by 60 percent time spent on documenting patient encounters, both during clinic hours and outside of regular work hours; and reduce cognitive load by 51 percent, according to Abridge.

“Abridge is clinically smart and feels like it has been trained with clinician thinking. It creates a note that resonates with me, reading like a clinician wrote it,” Jacobs said. “Abridge is the first thing I’ve seen that improves provider wellness and relieves cognitive load, allowing me to be fully present with my patient.” 

“Abridge has delivered spectacular results for our physicians and improved the patient experience,” said Sanders. “The superior quality of Abridge’s AI-generated note drafts made them the obvious choice by our Digital and Remote Health Committee for ambient documentation.”

UVM, an integrated system serving the residents of Vermont and northern New York, selected Abridge following a vetting process. Clinicians at the University of Vermont Health Network, which serves over one million patients, have been using Abridge for four months. The enterprise rollout will soon expand to cardiology, endocrinology, and other specialties.